Management and Advisors

Amos Michelson – Chairman

Amos Michelson was the Chief Executive Officer of Creo Inc. from June 1995 until Kodak purchased Creo in May 2005. He joined Creo in 1991 and served in positions including Vice President Business Strategy, Managing Director, and Chair of the Board of Directors until his appointment as CEO. Under Mr. Michelson’s leadership, Creo grew to employ over 4,000 personnel and generate $650 million USD annual revenue. Prior to joining Creo, Mr. Michelson was the CEO of Opal Inc., a semi-conductor equipment company and prior to this, he was the Chief Operating Officer of Optrotech Ltd., a developer and manufacturer of optical and imaging systems for the electronic industry.

Mr. Michelson is a past member of the Premier’s Technology Council and in 1999 was named Entrepreneur of the Year, along with Dan Gelbart, by Ernst & Young. In 2005, Mr. Michelson was named the BCTIA Person of the Year.

Mr. Michelson holds a MBA from Stanford Business School and a B.Sc. in electrical engineering from the Technion – Israel Institute of Technology.


Doug Goertzen – CEO

Prior to Kardium, Doug Goertzen held the position of General Manager, Proofing and Color at Eastman Kodak Company. Mr. Goertzen was responsible for the $55 million worldwide proofing and colour business and managed the 130 person team developing the proofing and colour product portfolio. He held senior positions in service, development and management during his 12 year tenure at Kodak and Creo Inc. (which was acquired by Kodak in 2005) and brings significant expertise in both product research and strategy to Kardium.

Mr. Goertzen graduated with a B.A.Sc. in electrical engineering from Simon Fraser University.


Prof. Hans Kottkamp – Advisor

Prof. Hans Kottkamp is the medical director of the electrophysiology department of the Klinik Hirslanden in Zurich, Switzerland. Prior to this, Prof. Kottkamp was appointed as Adjunct Professor of Internal Medicine at the Medical Faculty of the University of Leipzig and was the Medical Director, Department of Rhythmology at the Heart Centre Leipzig.

Prof. Kottkamp is a world renowned expert in the diagnosis and treatment of atrial fibrillation. He focuses on catheter ablation of supraventricular and ventricular arrhythmias with special emphasis on ablation of atrial fibrillation. He has more than 150 publications in international journals and monographs. Prof. Kottkamp is on the editorial board of the Journal of Cardiovascular Electrophysiology and Heart Rhythm. His clinical work deals with all aspects of interventional cardiac electrophysiology.


Dr. Sam Lichtenstein – Advisor

Dr. Sam Lichtenstein currently holds numerous senior medical positions including Head of the University of British Columbia Division of Cardiovascular Surgery, Head of Cardiovascular & Thoracic Surgery Division at St. Paul’s Hospital in Vancouver, Canada, and Member of the Residency Education Committee. He was also formerly Medical Director at the British Columbia Provincial Heart Centre.

Dr. Lichtenstein is a world renowned practitioner and researcher in cardiovascular surgery. He has made many significant contributions to heart surgery techniques during his career and has recently been featured on Fox News for performing the world’s first minimally invasive beating heart aortic valve replacement surgery.


Dan Gelbart – Advisor

Dan Gelbart co-founded Creo, a high tech company delivering products for the printing industry in 1984. He served as President and then Chief Technology Officer until July 2005, when Creo was sold to Kodak for $1 billion US. At the time of the sale, Creo had 4,000 employees and was the largest player in its field. A significant portion of Creo’s award-winning technology was developed by Mr. Gelbart.

Mr. Gelbart has over 100 US patents to his name and has received multiple awards, including the British Columbia Science Council Gold Medal (twice), Institute of Printing Gold Medal, Honorary Doctorate (from Simon Fraser University), and 1999 Entrepreneur of the Year, along with Amos Michelson, by Ernst & Young.

Mr. Gelbart holds a B.Sc. and M.Sc. in electrical engineering from the Technion – Israel Institute of Technology.


Dr. James Abel – Advisor

Dr. James Abel is Assistant Director of the Cardiac Surgery Division, Co-Director of the Cardiac Surgery Intensive Care Unit at St. Paul’s Hospital in Vancouver, Canada and a Clinical Associate Professor at the University of British Columbia, Division of Cardiovascular Surgery. He graduated from University of Toronto with a M.Pharm., as well as a M.D. A cardiovascular surgeon at St. Paul’s since 1993, his special areas of interest include mitral (heart) valve repair surgery, complex surgical procedures to help patients with severe heart failure avoid the need for a heart transplant, and surgical procedures to cure atrial fibrillation. Dr. Abel has been involved in clinical quality improvement initiatives in the program and numerous research studies and publications over the past two decades.


Dr. John Webb – Advisor

Dr. John Webb is currently a Clinical Professor at the University of British Columbia, Canada and Director of Cardiac Catheterization and Interventional Cardiology at St. Paul’s Hospital in Vancouver, Canada.

Dr Webb’s research interests include percutaneous management of valvular heart disease, myocardial infarction, shock and new device development. Vancouver currently has the largest and broadest percutaneous valve experience where active clinical programs include transarterial and transapical aortic and pulmonary valve implantation as well as conventional valvuloplasty and paravalvular leak closure. More experimental clinical mitral programs include annular stenting, suture plication and edge-to-edge repair procedures.


Dr. John Yeung – Advisor

Dr. John Yeung is one of the leading cardiologists in North America and specializes in percutaneous ablation treatment for atrial fibrillation. Dr. Yeung is a Clinical Professor in the Division of Cardiology, Department of Medicine at the University of British Columbia. He is also the Director of the Cardiac Electrophysiology Lab at St. Paul’s Hospital in Vancouver, Canada and leads a world-renowned cardiac ablation program.

Dr. Yeung graduated in medicine from the University Of Glasgow, Scotland. After doing his cardiology residency training at the University of Alberta, he trained in electrophysiology at the University of Oklahoma under Dr. W. Jackman. Dr. Yeung received a merit award as one of the finalists at the Young Investigator Award competition at NASPE (currently HRS).



Visit us on TwitterVisit us on FacebookVisit us on GooglePlusVisit us on Linkedin